Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8791459 | 0.78 | HPGD (0.54) | KMT2ANPC1RAB9AL3MBTL1GAA | |
| SCHEMBL7472113 | 0.77 | KMT2A (0.55) | KMT2ANPC1RAB9AL3MBTL1GAA | |
| SCHEMBL19457471 | 0.75 | LMNA (0.43) | KMT2AL3MBTL1GAANAMPTLMNA | |
| SCHEMBL15741530 | 0.74 | HPGD (0.56) | KMT2ANPC1RAB9AGAALMNA | |
| SCHEMBL20988114 | 0.74 | LMNA (0.42) | KMT2AL3MBTL1GAALMNAALDH1A1 | |
| SCHEMBL3370667 | 0.74 | PKM (0.60) | KMT2ANPC1RAB9AL3MBTL1MAPT | |
| SCHEMBL12031648 | 0.72 | RAB9A (0.50) | KMT2ANPC1RAB9AL3MBTL1ALDH1A1 | |
| SCHEMBL6360579 | 0.71 | NPC1 (0.59) | KMT2ANPC1RAB9AL3MBTL1MAPT | |
| SCHEMBL28364538 | 0.71 | KMT2A (0.55) | KMT2ANPC1RAB9AL3MBTL1GAA | |
| SCHEMBL31536380 | 0.70 | LMNA (0.46) | KMT2ANPC1RAB9AGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220323421-A1 | Soft Chewable Veterinary Dosage Form | INTERVET INC. (US) | 2022-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220323421-A1 | Soft Chewable Veterinary Dosage Form | SI, GYPA, CYP3A7 | KMT2A 427/4885NPC1 2467/4885RAB9A 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.